Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSYE2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,584
Award facts
- Contract value 100% obligated
- $11,584.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pen injectors with a ceiling value of $11,584.44. This is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order falls under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Cencora, Inc. holds the parent indefinite delivery contract with DLA through December 31, 2031. The Wegovy pharmaceutical product supplied under this order supports the Defense Health Agency and other federal military healthcare systems' medication needs. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains for the Department of Defense and related agencies.
Quick answers
Who was awarded contract SPE2DR26FSYE2?
SPE2DR26FSYE2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FSYE2 worth?
The government has obligated $11,584 on SPE2DR26FSYE2.
Is contract SPE2DR26FSYE2 an order under another contract?
Yes. SPE2DR26FSYE2 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSYE2 competed?
The extent of competition for SPE2DR26FSYE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award